CRISPR gene editing is a promising therapy for treating rare genetic diseases. Delivering this therapy directly to patients is challenging because the CRISPR cargo needs protection from degradation. For this reason, most successful CRISPR clinical trials use patient-derived cells that are corrected in vitro. New approaches in nanoparticle and virus delivery methods make it possible to edit disease-causing genes directly in the body. In this webinar, researchers will discuss in vivo gene editing advancements that open the door for treating a wide range of genetic disorders.
Topics to be covered
Speaker Information:
Niren Murthy, PhD
Professor
Department of Bioengineering
University of California, Berkeley
Hye Young Lee, PhD
Assistant Professor
Department of Cellular and Integrative Physiology
The University of Texas, Health Science Center at San Antonio
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy